Intrapleural use of tissue plasminogen activator and DNase in pleural infection
BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...
मुख्य लेखकों: | Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2011
|
समान संसाधन
-
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
द्वारा: Rahman, N, और अन्य
प्रकाशित: (2011) -
PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
द्वारा: Rahman, N, और अन्य
प्रकाशित: (2009) -
The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
द्वारा: Kanellakis, N, और अन्य
प्रकाशित: (2018) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
द्वारा: Kanellakis, N, और अन्य
प्रकाशित: (2019) -
Intrapleural streptokinase for pleural infection.
द्वारा: Maskell, N, और अन्य
प्रकाशित: (2006)